These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7772582)

  • 21. [Botulinum Toxin - New Developments in Ophthalmology].
    Wabbels B
    Klin Monbl Augenheilkd; 2018 Jun; 235(6):721-724. PubMed ID: 28114700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of blepharospasm with medication, surgery and type A botulinum toxin.
    Arthurs B; Flanders M; Codère F; Gauthier S; Dresner S; Stone L
    Can J Ophthalmol; 1987 Feb; 22(1):24-8. PubMed ID: 3815152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections.
    Elston JS
    Br J Ophthalmol; 1987 Sep; 71(9):664-8. PubMed ID: 3663559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of blepharospasm and hemifacial spasm.
    Elston JS
    J Neurol; 1992 Jan; 239(1):5-8. PubMed ID: 1541971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm.
    Kalra HK; Magoon EH
    Ophthalmic Surg; 1990 May; 21(5):335-8. PubMed ID: 2381655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can ptosis incidence be reduced after lid injections of botulinum A exotoxin for blepharospasm and hemifacial spasm?
    Carruthers J; Carruthers A; Bagaric D
    Can J Ophthalmol; 1995 Apr; 30(3):147. PubMed ID: 7627900
    [No Abstract]   [Full Text] [Related]  

  • 27. Botulinum toxin for treatment of Frey's syndrome: report of two cases.
    Teive HA; Troiano AR; Robert F; Iwamoto FM; Maniglia JJ; Mocellin M; Werneck LC
    Arq Neuropsiquiatr; 2003 Jun; 61(2A):256-8. PubMed ID: 12806506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crocodile tears syndrome: botulinum toxin treatment under EMG guidance.
    Kizkin S; Doganay S; Ozisik HI; Ozcan C
    Funct Neurol; 2005; 20(1):35-7. PubMed ID: 15948567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of differential section of the VIITH nerve on patients with intractable blepharospasm.
    Frueh BR; Callahan A; Dortzbach RK; Wilkins RB; Beale HL; Reitman HS; Watson FR
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(4 Pt 1):OP595-602. PubMed ID: 960382
    [No Abstract]   [Full Text] [Related]  

  • 30. [Botulinum toxin for ocular complications after facial palsy].
    Torres Suárez E
    Ophthalmologe; 2012 Mar; 109(3):292-6. PubMed ID: 22447427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired blepharoptosis secondary to essential blepharospasm.
    Bodker FS; Olson JJ; Putterman AM
    Ophthalmic Surg; 1993 Aug; 24(8):546-50. PubMed ID: 8233320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of dystonic blepharospasm and hemifacial spasm with botulinum toxin: preliminary studies].
    Martí MJ; Kulisevsky J; Tolosa E
    Med Clin (Barc); 1987 Sep; 89(8):321-3. PubMed ID: 3320608
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical outcome after surgery for 75 patients with parotid sialadenitis.
    Patel RS; Low TH; Gao K; O'Brien CJ
    Laryngoscope; 2007 Apr; 117(4):644-7. PubMed ID: 17415134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin.
    Mauriello JA
    Neurology; 1985 Oct; 35(10):1499-500. PubMed ID: 4033932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of facial synkinesis with Clostridium botulinum toxin injection.
    Mountain RE; Murray JA; Quaba A
    Clin Otolaryngol Allied Sci; 1992 Jun; 17(3):223-4. PubMed ID: 1505088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facial palsy-induced blepharospasm relieved by a Bangerter foil.
    Sagili S; Malhotra R; Elston J
    Mov Disord; 2005 Sep; 20(9):1231-2. PubMed ID: 16037921
    [No Abstract]   [Full Text] [Related]  

  • 37. Complications of parotid surgery: the need for selectivity.
    Owen ER; Banerjee AK; Kissin M; Kark AE
    Br J Surg; 1989 Oct; 76(10):1034-5. PubMed ID: 2597945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The absent facial nerve pes anserinus: implications for parotid surgery.
    Wong AS; Teh BM; Safdar A
    ANZ J Surg; 2016 Dec; 86(12):1067-1068. PubMed ID: 27910272
    [No Abstract]   [Full Text] [Related]  

  • 39. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis.
    Clark RP; Berris CE
    Plast Reconstr Surg; 2005 Feb; 115(2):573-4. PubMed ID: 15692366
    [No Abstract]   [Full Text] [Related]  

  • 40. Facial nerve function after parotidectomy.
    Bron LP; O'Brien CJ
    Arch Otolaryngol Head Neck Surg; 1997 Oct; 123(10):1091-6. PubMed ID: 9339986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.